Frontier Bio creates engineered tissues to replace animal testing and save lives. Recent recognition includes a Phase 1 win in the NIH Complement-ARIE Challenge for our AI + bio tissue platform and an NSF SBIR grant for a novel blood vessel fabrication method.
| Website | http://www.frontierbio.com |
| Revenue | $3 million |
| Employees | 8 (8 on RocketReach) |
| Founded | 2018 |
| Address | Pier 9, San Francisco, California 94111, US |
| Technologies |
JavaScript
,
HTML
,
Twitter
+13 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Biotechnology, Bioprinting, Business Services, Science and Engineering, Manufacturing |
| Keywords | Bioscience, Biopharmaceutical, Tissue Engineering, Regenerative Medicine, In Vitro Testing, Drug Discovery, Biotechnology, Pharmaceutical Research, Preclinical Testing, 3d Bioprinting, Cell Culture, Organoids, Toxicology Testing, Safety Testing, Efficacy Testing |
| Competitors | Amgen, Regeneron, Vertex Pharmaceuticals, Genentech, Gilead Sciences, Bristol Myers Squibb, Lilly India, AbbVie, Pfizer, AstraZeneca +40 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies |
Looking for a particular Frontier Bio employee's phone or email?
The Frontier Bio annual revenue was $3 million in 2026.
Eric Bennett is the CEO of Frontier Bio.
8 people are employed at Frontier Bio.
Frontier Bio is based in San Francisco, California.
The NAICS codes for Frontier Bio are [541, 5417, 54171, 54, 541713].
The SIC codes for Frontier Bio are [873, 87].